Nanoveu Ltd. · ASX:NVU
Nanoveu — H1 FY2021 Earnings Presentation
18 slides from Nanoveu's earnings presentation, Sep 10, 2021
Slide 1: Half-year Results Webinar Presentation ASX Release
Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com For personal use only ASX RELEASE 10 September 2021 ASX: NVU Half-year Results Webinar Presentation Nanoveu Limited (“Nanoveu”) presented its FY2021 half-year results at a webinar held on Friday 10 September from 10:
Slide 2: FY2021 Half-Year Results | Investor Presentation
For personal use only FY2021 HALF-YEAR RESULTS | INVESTOR PRESENTATION 10 SEPTEMBER 2021 (ASX:NVU)
Slide 3: Disclosure and Disclaimer
DISCLOSURE AND DISCLAIMER For personal use only § The information in this presentation has been prepared by Nanoveu for the purposes of providing an overview of the company and its products. § This presentation does not constitute investment advice. Neither does this presentation nor the information
Slide 4: Key FY2021 Half-Year Results Highlights
KEY FY2021 HALF-YEAR RESULTS HIGHLIGHTS For personal use only ü 2,032% increase in revenue ü Record breaking Q2 FY2021 ü Global expansion with new contracts in ü Sales of NanoshieldTM continue to Australia expand as the business continues to work with global high-quality distributions partners ü Nan
Slide 5: Company Overview
COMPANY OVERVIEW For personal use only ¡ Incorporated in 2012, IPO in Nov 2018 ¡ Collaboration with ASTAR and NTU – in Singapore for its R&D ¡ Experts in harnessing nano-technology to solve major problems, including anti-viral digital screen protection ¡ Revolutionary anti-viral digital device prote
Slide 6: Highly Experienced Board and Management
HIGHLY EXPERIENCED BOARD AND MANAGEMENT For personal use only Alfred Chong Steven Apedaile Executive Chairman & Chief Executive Officer Non-executive Director § Serial technology entrepreneur and founder of § Approximately 30 years’ experience in Nanoveu international business, corporate finance and
Slide 7: Placement and Entitlement Issue
PLACEMENT AND ENTITLEMENT ISSUE For personal use only Placement - completed: Entitlement Issue – in progress: ¡ Shares: ¡ Shares: ¡ $1,350,000 (before costs) ¡ $2,152,800 (before costs) ¡ $0.045 per share ¡ $0.045 per share ¡ 30,000,000 fully paid ordinary shares ¡ 47,920,001 fully paid ordinary sha
Slide 8: Product Development Timeline
PRODUCT DEVELOPMENT TIMELINE For personal use only 2017 2020 EyeFly3D phone screen protector launched with ability to produce 3D 2021 graphics on devices Nanoshield™, without SD glasses developed and launched in early 2020, 2022 We are continuing to with manufacturing CustomSkins lamination review t
Slide 9: Benefits of Nanoshield
BENEFITS OF NANOSHIELD™ For personal use only MADE IN PET Film –Visible Advanced Optical clarity Easy installation Lab tested with in antiviral manufacturing for touchscreens with a variety of Singapore, USA, Australia, protection in Japan – made with plastic options – India, China, Japan and nano m
Slide 10: Independent Testing Proves Technology Works
INDEPENDENT TESTING PROVES TECHNOLOGY WORKS For personal use only Nanoshield™ Technology has been independently tested against selected bacteria and viruses in accordance with the relevant ISO standards1. 1. See ASX Announcements of 15 April 2020, 5 May 2020, 25 May 2020, 18 February 2021 and 28 Jul
Slide 11: Nanoshield Film Solution is Visible and Proven
NANOSHIELDTM FILM SOLUTION IS VISIBLE AND PROVEN For personal use only * See ASX Announcements of 15 April 2020, 5 May 2020, 25 May 2020, 18 February 2021 and 28 July 2021 for the testing performed and the results. 10
Slide 12: Sales Development
SALES DEVELOPMENT For personal use only Nanoshield™ Distributors and Sales Networks ¡ Expanding list of international distributors ¡ Capital efficient method to accelerate sales ¡ Capitalises on international demand for intuitive antiviral protection ¡ Exclusivity utilised to incentivise sales for d
Slide 13: Revenue Growth
REVENUE GROWTH For personal use only 250,000 ¡ FY2021 Half-year results saw a 2,032% revenue increase 200,000 ¡ June ‘21 delivered a record quarterly Receipts from customers cashflow 150,000 ¡ Increasing number of distribution partners 100,000 ¡ Increasing application of product to new markets 50,00
Slide 14: Flagship Customer
FLAGSHIP CUSTOMER For personal use only ¡ Nestlé Professional secured as a Nanoshield direct customer1 ¡ Nanoshield applied to Nestlé Professional coffee machines: ¡ Nescafé touch screens ¡ We Proudly Serve Starbucks® machine screens ¡ To date, Nestlé Professional orders from regional divisions incl
Slide 15: Nanoshield Antiviral Protection for Armaguard
NANOSHIELD ANTIVIRAL PROTECTION FOR ARMAGUARD For personal use only ¡ Nanoveu’s Australian distributor High Touch is helping keep Australians safe with a range of Nanoshield films. ¡ High Touch’s agreement for Nanoshield antiviral surface protection for Armaguard’s extensive network of ATMs, self se
Slide 16: Corporate Snapshot - One-Year Price Chart
CORPORATE SNAPSHOT - ONE-YEAR PRICE CHART For personal use only Corporate details* Major shareholders Shares on issue 191.4m Board and management 58.3% Options on issue 7.2m Top 20 23.3% Current share price (8 Sept. 2021) $0.043 Market cap. $8.23m 52 week high - low $0.040 - $0.110 Data as at 08 Sep
Slide 17: Investment Proposition
INVESTMENT PROPOSITION For personal use only ¡ Low capital investment for new products ¡ Expanded product range year-on-year ¡ Successful commercialisation of Nanoshield™ with securing of flagship customer, Nestlé Group’s Professional Services Unit ¡ Strong network of International Distributors for
Slide 18: For personal use only
For personal use only www.nanoshield.co | www.nanoveu.com | [email protected] Nanoshield™ Is a registered Trade Mark of Nanoveu. 17